IMMUNOCAN

Toward enhancing activities of European institutions in the FDUSCC-IM cancer research joint institute in China

Coordinatore	TRANSGENE SA    more  Organization address address: BOULEVARD GONTHIER D ANDERNACH - PARC D'INNOVATION city: ILLKIRCH-GRAFFENSTADEN postcode: 67405 contact info Titolo: Dr. Nome: Romain Cognome: Micol Email: send email Telefono: 33617336709 Fax: 33369227550
Nazionalità Coordinatore	France [FR]
Totale costo	2˙072˙438 €
EC contributo	1˙992˙214 €
Programma	FP7-INCO Specific Programme "Capacities": International co-operation
Code Call	FP7-INCO-2011-7
Funding Scheme	CSA-SA
Anno di inizio	2012
Periodo (anno-mese-giorno)	2012-01-01   -   2015-12-31

 Partecipanti

#	participant	country	role	EC contrib. [€]
1	TRANSGENE SA  Organization address address: BOULEVARD GONTHIER D ANDERNACH - PARC D'INNOVATION city: ILLKIRCH-GRAFFENSTADEN postcode: 67405 contact info Titolo: Dr. Nome: Romain Cognome: Micol Email: send email Telefono: 33617336709 Fax: 33369227550	FR (ILLKIRCH-GRAFFENSTADEN)	coordinator	570˙009.00
2	FUDAN UNIVERSITY SHANGHAI CANCER CENTER  Organization address address: DONGAN ROAD 270 - XUHUI DISTRICT city: SHANGHAI postcode: 200032 contact info Titolo: Prof. Nome: Jiong Cognome: Wu Email: send email Telefono: +86 13601637369 Fax: 862164000000	CN (SHANGHAI)	participant	761˙908.00
3	KOBENHAVNS UNIVERSITET	DK	participant	255˙409.00
4	MEDIZINISCHE HOCHSCHULE HANNOVER  Organization address address: Carl-Neuberg-Strasse 1 city: HANNOVER postcode: 30625 contact info Titolo: Prof. Nome: Roland Cognome: Jacobs Email: send email Telefono: +49 511 532 3581 Fax: +49 511 532 5648	DE (HANNOVER)	participant	239˙359.00
5	FONDAZIONE IRCCS ISTITUTO NAZIONALE DEI TUMORI  Organization address address: Via Venezian 1 city: Milan postcode: 20133 contact info Titolo: Mr. Nome: Antonio Cognome: Cannarozzo Email: send email Telefono: 390224000000 Fax: 390224000000	IT (Milan)	participant	165˙529.00

Mappa

 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

 Obiettivo del progetto (Objective)

'The joint institute Fudan University Shanghai Cancer Centre – Institut Mérieux laboratory (FDUSCC-IM), created in May 2010, is conducting ambitious scientific research projects on oncology in China. Its 2 founding partners, Fudan University (China) and Transgene (part of Institut Mérieux, France) wish to increase their translational medical research cooperation with European countries. In a first step, collaboration will enlarge to an active partnership with Danish, Italian and German teams, with the following objectives: (i) increase the EU-China knowledge exchanges in the field of cancer prognosis – by organizing in China summer schools, seminars and international conferences, as well as by hosting PhDs and post PhD research fellows in the joint institute, (ii) enhance the research capacity and the technological transfer to the joint institute – by providing adequate human resources and equipment to conduct beyond the state-of-the-art oncology research, (iii) promote a reference Euro-Asian centre on Chinese cancer prognosis – by spreading the knowledge and by raising awareness in China and European Union. Research activities will be held in China in collaboration with the new European partners, in order to enhance current research activities of the joint institute and to create durable links between Chinese and European teams. Current research is focused on immune phenotype as personalized medical biomarker for prognosis of Chinese cancer patients, and will be extended to new types of cancer and biomarkers. These prognosis studies will help to guide clinical decision-making by facilitating the selection of appropriate treatment options. Ultimately, this FP7 INCOLAB is an opportunity to build a Euro-Asian reference centre for medical and scientific research on cancer and to extend the already existing cooperation between the FDUSCC-IM laboratory and Europe by considering the opening of the joint institute to additional European member.'